Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
1.
Planta Med ; 90(4): 286-297, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38286405

RESUMEN

Extracellular senile plaques and intraneuronal neurofibrillary tangles are two devastating brain proteinopathies that are indicative of Alzheimer's disease, the most prevalent type of dementia. Currently, no effective medications are available to stop or reverse Alzheimer's disease. Ginkgo biloba extract, commonly referred to as EGb 761, is a natural product made from the leaves of the G. biloba tree. It has long been demonstrated to have therapeutic benefits in Alzheimer's disease. The current study assessed the beneficial effects of EGb 761 against Alzheimer's disease in comparison with memantine, a standard treatment for Alzheimer's disease. The scopolamine-heavy metals mixture rat Alzheimer's disease model is a newly created model to study the effects of EGb 761 oral therapy on cognitive performance and other Alzheimer's disease-like changes over a 28-day experimental period. This new Alzheimer's disease model provides better criteria for Alzheimer's disease hallmarks than the conventional scopolamine model. The EGb 761 reversed memory and learning deficits induced by the scopolamine-heavy metals mixture. These outcomes were linked to a more pronounced inhibitory effect on acetylcholinesterase, caspase-3, hippocampal amyloid-beta protein (Aß1 - 42), phosphorylated tau protein counts, and proinflammatory cytokines (tumor necrosis factor-α and interleukin-1ß) compared to the memantine-treated group. Furthermore, EGb 761 treatment considerably reduced lipid peroxidation (malondialdehyde) and improved reduced glutathione levels compared to memantine. Our results suggest EGb 761's potential in treating central nervous system disorders. It's a promising candidate for future Alzheimer's disease therapeutic exploration. This study also highlights the need for future research to focus on the positive benefits of herbal medicines.


Asunto(s)
Enfermedad de Alzheimer , Disfunción Cognitiva , Extracto de Ginkgo , Metales Pesados , Animales , Ratas , Enfermedad de Alzheimer/tratamiento farmacológico , Memantina/farmacología , Memantina/uso terapéutico , Ginkgo biloba , Acetilcolinesterasa/uso terapéutico , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Disfunción Cognitiva/tratamiento farmacológico , Metales Pesados/uso terapéutico , Derivados de Escopolamina/uso terapéutico
2.
G Ital Cardiol (Rome) ; 23(6): 477-480, 2022 Jun.
Artículo en Italiano | MEDLINE | ID: mdl-35674039

RESUMEN

Cardiovascular complications are among the main causes of mortality and morbidity in patients with thalassemia major. Iron-chelation therapy is essential to prevent the chronic iron overload linked to the need for transfusions and the consequent cardiac hemosiderosis. Despite the wide use of iron-chelation drugs, today it is still possible to find cases of severe iron accumulation. Furthermore, even regardless of iron overload and cardiac dysfunction, the thalassemic patient has a high arrhythmic burden, especially for supraventricular arrhythmias. There are still many doubts and open questions about the management of such patients, especially regarding the correct use of anticoagulant therapy and the best utilization of therapeutic strategies available for rhythm control. The case presented shows how the interventional approach with catheter ablation can be useful also in the acute phase when antiarrhythmic drugs are ineffective and it is not possible to wait for the iron-chelation therapy to take effect.


Asunto(s)
Cardiopatías , Sobrecarga de Hierro , Metales Pesados , Talasemia beta , Arritmias Cardíacas/etiología , Arritmias Cardíacas/terapia , Cardiopatías/complicaciones , Humanos , Hierro/uso terapéutico , Quelantes del Hierro/uso terapéutico , Sobrecarga de Hierro/complicaciones , Sobrecarga de Hierro/tratamiento farmacológico , Metales Pesados/uso terapéutico , Talasemia beta/tratamiento farmacológico , Talasemia beta/terapia
3.
Chembiochem ; 21(21): 3044-3046, 2020 11 02.
Artículo en Inglés | MEDLINE | ID: mdl-32896976

RESUMEN

The vast majority of investigated compounds in modern medicine are based on organic molecules. Within the last decades, the field of medicinial chemistry is shifting towards the application of metal complexes. These compounds offer different mechanisms of action in comparison to organic molecules due to their unique properties, making them novel drug candidates. Herein, the successful combination of metal containing compounds and medicine is highlighted by their application for photodynamic therapy.


Asunto(s)
Antineoplásicos/farmacología , Complejos de Coordinación/farmacología , Metales Pesados/uso terapéutico , Neoplasias/tratamiento farmacológico , Fotoquimioterapia , Fármacos Fotosensibilizantes/farmacología , Animales , Antineoplásicos/síntesis química , Antineoplásicos/química , Investigación Biomédica , Complejos de Coordinación/síntesis química , Complejos de Coordinación/química , Humanos , Metales Pesados/química , Neoplasias/inmunología , Neoplasias/patología , Fármacos Fotosensibilizantes/síntesis química , Fármacos Fotosensibilizantes/química
4.
Chembiochem ; 21(19): 2706-2707, 2020 10 01.
Artículo en Inglés | MEDLINE | ID: mdl-32588495

RESUMEN

On the 14-15th November 2019, the first workshop on Metals in Medicine took place in Paris at Chimie ParisTech, PSL University. Organised with the aim of having invited speakers share their experience in bringing metal-based drugs to (pre-)clinical trials, this event gathered 135 attendees from six continents to Paris. A special collection on this event has now been published in ChemBioChem, combining more than 20 articles on different topics related to metals in medicine.


Asunto(s)
Química Bioinorgánica , Congresos como Asunto , Desarrollo de Medicamentos , Metales Pesados/uso terapéutico , Humanos , Metales Pesados/química , Neoplasias/tratamiento farmacológico , Paris , Investigación Biomédica Traslacional
5.
Biomolecules ; 9(7)2019 07 09.
Artículo en Inglés | MEDLINE | ID: mdl-31324037

RESUMEN

The present review reports a list of approximately 800 compounds which have been used, tested or proposed for Parkinson's disease (PD) therapy in the year range 2014-2019 (April): name(s), chemical structure and references are given. Among these compounds, approximately 250 have possible or established metal-chelating properties towards Cu(II), Cu(I), Fe(III), Fe(II), Mn(II), and Zn(II), which are considered to be involved in metal dyshomeostasis during PD. Speciation information regarding the complexes formed by these ions and the 250 compounds has been collected or, if not experimentally available, has been estimated from similar molecules. Stoichiometries and stability constants of the complexes have been reported; values of the cologarithm of the concentration of free metal ion at equilibrium (pM), and of the dissociation constant Kd (both computed at pH = 7.4 and at total metal and ligand concentrations of 10-6 and 10-5 mol/L, respectively), charge and stoichiometry of the most abundant metal-ligand complexes existing at physiological conditions, have been obtained. A rigorous definition of the reported amounts is given, the possible usefulness of this data is described, and the need to characterize the metal-ligand speciation of PD drugs is underlined.


Asunto(s)
Quelantes/uso terapéutico , Terapia por Quelación , Complejos de Coordinación/uso terapéutico , Metales Pesados/uso terapéutico , Fármacos Neuroprotectores/uso terapéutico , Enfermedad de Parkinson/tratamiento farmacológico , Quelantes/síntesis química , Quelantes/química , Complejos de Coordinación/síntesis química , Complejos de Coordinación/química , Humanos , Ligandos , Metales Pesados/síntesis química , Metales Pesados/química , Fármacos Neuroprotectores/síntesis química , Fármacos Neuroprotectores/química , Termodinámica
7.
Recent Pat Antiinfect Drug Discov ; 13(2): 164-179, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29984669

RESUMEN

BACKGROUND: Hospital wastewater has a high amount of both organic and inorganic matter, as well as high densities of living organisms, including pathogenic, and environmental bacteria. It has been suggested that genes encoding resistance to an antibiotic can be located together with heavy metals resistance genes on either the same genetic structure (plasmid) or different genetic structures within the same bacterial strain. Resistance transfer is mainly attributed to conjugation since many antimicrobial resistance genes are situated on mobile elements, such as plasmids and conjugative transposons, whereas renovation and transduction are usually more limited. Our study confirmed the flow of resistance genes between indigenous and foreign organisms and indicated the possibility of resistance transfer from environmental reservoirs to pathogenic strains, which should be underlined in the future. The recent patents on drug resistance (US20030130169, WO/2001/060387, WO/2016/151092) and gene transfer (JP2003189855, JP2010094090), helped in this study. METHODS: Water samples were collected from three different sites of hospital wastewater. Isolation of Gram-negative bacteria from hospital wastewater samples was done using the standard microbial procedure. The heavy metal resistance was determined by the minimum inhibitory concentration (MIC) against the test bacterial strain by spot plate method. The antibiotic resistance was determined by a standard disc diffusion technique. The bacterial resistance transfer studies were determined between donor and recipient strain in nutrient as well as wastewater. The antibiogram and MIC of the donors and transconjugants were studied by above-described methods. RESULTS: A high number of Gram-Negative Bacterial Isolates (GNB) exhibited antibiotic and metal resistance transfer into E. coli K-12 and similar GNB isolates in nutrient broth as compared to wastewater. The microbial conjugation experiments showed that a high percentage of multi-resistant GNB (75% and 66%) was able to transfer their single or multidrug resistance patterns to E. coli K-12 among antibiotic while 58%, 66% of the multiresistant isolates were able to transfer their single or multi-metal resistance patterns to E. coli K-12 among metal in nutrient medium and wastewater, respectively. In the present conjugation study, 97.5% and 70% of the total tested GNB isolates were able to transfer an antibiotic-resistant marker to recipient GNB in both the medium (nutrient medium and wastewater), whereas 92.5% and72.5% of the isolates were able to transfer metal resistant marker to recipient GNB in nutrient medium and wastewater from all the site tested. The higher (6.8x10-1 and 5.9x10-1) frequency of transfer was observed among antibiotic and metal while the lower frequency of transfer was (7.0x10-3 and 2.0x10-3) exhibited against antibiotic and metal in both the medium from the entire site tested, respectively. CONCLUSION: We can recommend that the hospital water is heavily polluted with several types of antibiotics, toxic metals as well as the potentially hazardous bacterial flora because of their capacity to resist one or the other well known antibiotic and chemotherapeutic agents. These studies provide evidence that a wide variety of clinically important antibiotic and metal resistance genes is mobile within aquatic bacterial communities one step ahead of the above, we can envisage the alarming situation prevailing in our system and surrounding in the light of transmissible nature of R-plasmids.


Asunto(s)
Antibacterianos/farmacología , Farmacorresistencia Bacteriana Múltiple/genética , Bacterias Gramnegativas/fisiología , Metales Pesados/farmacología , Aguas Residuales/microbiología , Antibacterianos/uso terapéutico , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Flujo Génico , Transferencia de Gen Horizontal , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Gramnegativas/aislamiento & purificación , Infecciones por Bacterias Gramnegativas/tratamiento farmacológico , Infecciones por Bacterias Gramnegativas/microbiología , Hospitales , Humanos , India , Eliminación de Residuos Sanitarios , Metales Pesados/uso terapéutico , Pruebas de Sensibilidad Microbiana , Patentes como Asunto , Plásmidos/genética
8.
Mol Cell Endocrinol ; 457: 57-72, 2017 Dec 05.
Artículo en Inglés | MEDLINE | ID: mdl-27773847

RESUMEN

Prostate cancer is the most common cancer in men in many industrialized countries. A role for androgens in prostate tumor progression is well recognized, while estrogens may cooperate with androgens in prostate carcinogenesis. The incidence of prostate cancer is highly variable in the different countries, suggesting an important role of environmental factors. Heavy metals are common environmental contaminants and some of them are confirmed or suspected human carcinogens. Some metals are endowed with estrogenic and/or androgenic activities and may play a role as cancer risk factors through this mechanism. Moreover, prostate cancer may present alterations in the intracellular balance of trace metals, such as zinc and copper, which are involved in several regulatory proteins. Herein, we review the possible role of environmental heavy metals and of metal-dyshomeostasis in prostate cancer development and promotion as well as the potential use of some metals in the prevention and therapy of prostate cancer.


Asunto(s)
Antineoplásicos/uso terapéutico , Metales Pesados/toxicidad , Metales Pesados/uso terapéutico , Neoplasias de la Próstata/inducido químicamente , Neoplasias de la Próstata/tratamiento farmacológico , Animales , Carcinogénesis/patología , Humanos , Masculino , Modelos Biológicos , Neoplasias de la Próstata/epidemiología , Factores de Riesgo
10.
Curr Pharm Des ; 22(26): 3996-4010, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27197799

RESUMEN

BACKGROUND: Alzheimer's disease (AD) is the most common form of dementia that seriously affects daily life. Even if AD pathogenesis is still subject of debate, it is generally accepted that cerebral cortex plaques formed by aggregated amyloid-ß (Aß) peptides can be considered a characteristic pathological hallmark. It is well known that metal ions play an important role in the aggregation process of Aß. METHODS: This review focuses on the anti-Aß aggregation activity of chelating ligands as well as on the use of metal complexes as diagnostic probes and as potential drugs. CONCLUSION: While chelating agents, such as curcumin or flavonoid derivatives, are currently used to capture metal ions responsible for Aß aggregation, the potential application of platinum, ruthenium and cobalt complexes, among others, of several heterocyclic ligands, represents a promising new strategy to fight AD.


Asunto(s)
Enfermedad de Alzheimer/tratamiento farmacológico , Péptidos beta-Amiloides/antagonistas & inhibidores , Complejos de Coordinación/farmacología , Metales Pesados/farmacología , Enfermedad de Alzheimer/diagnóstico , Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/metabolismo , Animales , Complejos de Coordinación/química , Complejos de Coordinación/uso terapéutico , Humanos , Metales Pesados/química , Metales Pesados/uso terapéutico , Agregado de Proteínas/efectos de los fármacos
11.
Nutrition ; 32(6): 617-9, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26921066

RESUMEN

Tendon injures cause a great deal of disability and pain, and increase medical costs. However, relatively little is known about tendon biology and healing. Many tendon-related surgical procedures are not very successful and leave the patient with essentially a chronic injury. New therapeutic approaches for tendon injury are needed. Preliminary evidence suggests that various nutrients such as proteins, amino acids (leucine, arginine, glutamine), vitamins C and D, manganese, copper, zinc, and phytochemicals may be useful in improving tendon growth and healing. More research on nutrition and tendon health is needed. Because many nutrients are required for tendon health, nutritional interventions involving multiple nutrients may be more effective than single-nutrient strategies. In the future, ideal treatment regimens for tendon injuries may include a multifaceted "bundle" of nutrition, drugs, biologic products, extracellular matrix therapies, exercise/physical therapy, and possibly surgery.


Asunto(s)
Aminoácidos/uso terapéutico , Metales Pesados/uso terapéutico , Fenómenos Fisiológicos de la Nutrición/fisiología , Traumatismos de los Tendones/dietoterapia , Vitaminas/uso terapéutico , Cicatrización de Heridas/efectos de los fármacos , Animales , Humanos , Fitoquímicos/uso terapéutico , Cicatrización de Heridas/fisiología
12.
Drug Discov Today Technol ; 16: 7-15, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26547416

RESUMEN

Understanding the mechanism of action of anti-cancer agents is of paramount importance for drug development. NMR spectroscopy can provide insights into the kinetics and thermodynamics of the binding of metallodrugs to biomolecules. NMR is most sensitive for highly abundant I=1/2 nuclei with large magnetic moments. Polarization transfer can enhance NMR signals of insensitive nuclei at physiologically-relevant concentrations. This paper reviews NMR methods for speciation of precious metal anti-cancer complexes, including platinum-group and gold-based anti-cancer agents. Examples of NMR studies involving interactions with DNA and proteins in particular are highlighted.


Asunto(s)
Antineoplásicos/química , Complejos de Coordinación/química , Espectroscopía de Resonancia Magnética/métodos , Metales Pesados/química , Neoplasias/diagnóstico , Neoplasias/tratamiento farmacológico , Animales , Antineoplásicos/uso terapéutico , Complejos de Coordinación/uso terapéutico , Oro/química , Oro/uso terapéutico , Humanos , Metales Pesados/uso terapéutico , Platino (Metal)/química , Platino (Metal)/uso terapéutico , Rodio/química , Rodio/uso terapéutico
13.
Artículo en Inglés | MEDLINE | ID: mdl-25521618

RESUMEN

There are an abundance of nanoparticle technologies being developed for use as part of therapeutic strategies. This review focuses on a narrow class of metal nanoparticles that have therapeutic potential that is a consequence of elemental composition and size. The most widely known of these are gold nanoshells that have been developed over the last two decades for photothermal ablation in superficial cancers. The therapeutic effect is the outcome of the thickness and diameter of the gold shell that enables fine tuning of the plasmon resonance. When these metal nanoparticles are exposed to the relevant wavelength of light, their temperature rapidly increases. This in turn induces a localized photothermal ablation that kills the surrounding tumor tissue. Similarly, gold nanoparticles have been developed to enhance radiotherapy. The high-Z nature of gold dramatically increases the photoelectric cross-section. Thus, the photoelectric effects are significantly increased. The outcome of these interactions is enhanced tumor killing with lower doses of radiation, all while sparing tissue without gold nanoparticles. Silver nanoparticles have been used for their wound healing properties in addition to enhancing the tumor-killing effects of anticancer drugs. Finally, platinum nanoparticles are thought to serve as a reservoir for platinum ions that can induce DNA damage in cancer cells. The future is bright with the path to clinical trials is largely cleared for some of the less complex therapeutic metal nanoparticle systems.


Asunto(s)
Antibacterianos/uso terapéutico , Infecciones Bacterianas/tratamiento farmacológico , Nanopartículas del Metal/uso terapéutico , Metales Pesados/uso terapéutico , Neoplasias/tratamiento farmacológico , Fotoquimioterapia/métodos , Animales , Antibacterianos/química , Oro/química , Oro/uso terapéutico , Humanos , Nanopartículas del Metal/química , Metales Pesados/química , Fármacos Fotosensibilizantes/química , Fármacos Fotosensibilizantes/uso terapéutico , Platino (Metal)/química , Platino (Metal)/uso terapéutico , Plata/química , Plata/uso terapéutico
15.
PLoS One ; 8(7): e65891, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23861740

RESUMEN

BACKGROUND: There are concerns that metal-on-metal hip implants may cause cancer. The objective of this study was to evaluate patterns and timing of risk of cancer in patients with metal-on-metal total hip replacements (THR). METHODS: In a linkage study between the English National Joint Registry (NJR) and the Clinical Practice Research Datalink (CPRD), we selected all THR surgeries (NJR) between 2003 and 2010 (n = 11,540). THR patients were stratified by type of bearing surface. Patients were followed up for cancer and Poisson regression was used to derive adjusted relative rates (RR). RESULTS: The risk of cancer was similar in patients with hip resurfacing (RR 0.69; 95% Confidence Interval [CI] 0.39-1.22) or other types of bearing surfaces (RR 0.96; 95% CI 0.64-1.43) compared to individuals with stemmed metal-on-metal THR. The pattern of cancer risk over time did not support a detrimental effect of metal hip implants. There was substantial confounding: patients with metal-on-metal THRs used fewer drugs and had less comorbidity. CONCLUSIONS: Metal-on-metal THRs were not associated with an increased risk of cancer. There were substantial baseline differences between the different hip implants, indicating possibility of confounding in the comparisons between different types of THR implants.


Asunto(s)
Artroplastia de Reemplazo de Cadera/estadística & datos numéricos , Registros Electrónicos de Salud/estadística & datos numéricos , Metales Pesados/uso terapéutico , Sistema de Registros , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Artroplastia de Reemplazo de Cadera/efectos adversos , Inglaterra , Femenino , Prótesis de Cadera/efectos adversos , Humanos , Masculino , Persona de Mediana Edad , Neoplasias/etiología , Análisis de Regresión , Estudios Retrospectivos , Riesgo , Sesgo de Selección
16.
Ugeskr Laeger ; 175(25): 1785-9, 2013 Jun 17.
Artículo en Danés | MEDLINE | ID: mdl-23773217

RESUMEN

A large number of materials used in the diagnosis, treatment and prevention of dental, periodontal and oral mucosal diseases may induce acute or chronic reactions in the oral cavity including allergic reactions. Clinically, it may be difficult to discriminate oral mucosal changes caused by dental materials from changes related to oral mucosal diseases. Diagnosis and management of allergic reactions in the oral mucosa may therefore be a major challenge. The purpose of this paper is to draw attention to commonly used dental materials, which can trigger typical, but also atypical, symptoms and clinical signs of an allergic reaction.


Asunto(s)
Materiales Dentales/efectos adversos , Hipersensibilidad Tardía/etiología , Hipersensibilidad Inmediata/etiología , Acrilatos/efectos adversos , Acrilatos/uso terapéutico , Materiales Dentales/uso terapéutico , Diagnóstico Diferencial , Humanos , Hipersensibilidad Tardía/diagnóstico , Hipersensibilidad Inmediata/diagnóstico , Látex/efectos adversos , Látex/uso terapéutico , Hipersensibilidad al Látex/diagnóstico , Hipersensibilidad al Látex/etiología , Metales Pesados/efectos adversos , Metales Pesados/uso terapéutico , Enfermedades de la Boca/diagnóstico , Enfermedades de la Boca/etiología
17.
ScientificWorldJournal ; 2013: 219840, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23690738

RESUMEN

Toxic metals such as arsenic, cadmium, lead, and mercury are ubiquitous, have no beneficial role in human homeostasis, and contribute to noncommunicable chronic diseases. While novel drug targets for chronic disease are eagerly sought, potentially helpful agents that aid in detoxification of toxic elements, chelators, have largely been restricted to overt acute poisoning. Chelation, that is multiple coordination bonds between organic molecules and metals, is very common in the body and at the heart of enzymes with a metal cofactor such as copper or zinc. Peptides glutathione and metallothionein chelate both essential and toxic elements as they are sequestered, transported, and excreted. Enhancing natural chelation detoxification pathways, as well as use of pharmaceutical chelators against heavy metals are reviewed. Historical adverse outcomes with chelators, lessons learned in the art of using them, and successes using chelation to ameliorate renal, cardiovascular, and neurological conditions highlight the need for renewed attention to simple, safe, inexpensive interventions that offer potential to stem the tide of debilitating, expensive chronic disease.


Asunto(s)
Quelantes/farmacocinética , Quelantes/uso terapéutico , Terapia por Quelación/métodos , Intoxicación por Metales Pesados , Metales Pesados/farmacocinética , Intoxicación/metabolismo , Animales , Humanos , Metales Pesados/química , Metales Pesados/metabolismo , Metales Pesados/uso terapéutico
18.
J Altern Complement Med ; 18(7): 719-22, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22830973

RESUMEN

BACKGROUND: Ayurvedic medicines are often considered effective for treating chronic and lifestyle-related diseases only and have not been thoroughly evaluated for treating acute or terminal illnesses. A prospective evaluation of Ayurvedic intervention was proposed for a patient who had metastatic liver disease with abnormal liver functions. The reason given for this was that no other conventional therapies were feasible in this case, and the family and caregivers were not willing to opt for any other intervention. MATERIALS AND METHODS: A diagnosed patient with metastatic liver disease that included abnormal liver functions and symptomatic presentation was treated with Ayurvedic therapies and was observed for 10 days for any possible changes. RESULTS: A substantial clinical and biochemical improvement was observed in this patient after 10 days of treatment. This improvement was noted to be consistent at a 1-week follow-up after the patient was discharged from the hospital. CONCLUSIONS: This case offers an opportunity to reconsider whether or not the toxic potentials of heavy metals used in Ayurvedic agents outweigh the possible benefits for treating patients with well-defined, incurable clinical conditions.


Asunto(s)
Antineoplásicos/uso terapéutico , Neoplasias Hepáticas/tratamiento farmacológico , Hígado/efectos de los fármacos , Medicina Ayurvédica , Metales Pesados/uso terapéutico , Anciano , Antineoplásicos/efectos adversos , Femenino , Neoplasias de la Vesícula Biliar/patología , Humanos , Neoplasias Hepáticas/secundario , Metales Pesados/efectos adversos
19.
J Biomed Mater Res B Appl Biomater ; 78(2): 296-301, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16362965

RESUMEN

Monosodium titanate (MST) is an inorganic sorbent/ion exchanger developed for the removal of radionuclides from nuclear wastes. We investigated the ability of MST to bind Cd(II), Hg(II), Au(III), or the Au-organic compound auranofin to establish the utility of MST for applications in environmental decontamination or medical therapy (drug delivery). Adsorption isotherms for MST were determined at pH 7-7.5 in water or phosphate-buffered saline. The extent of metal binding was determined spectroscopically by measuring the concentrations of the metals in solution before and after contact with the MST. Cytotoxic responses to MST were assessed using THP1 monocytes and succinate dehydrogenase activity. Monocytic activation by MST was assessed by TNFalpha secretion (ELISA) with or without lipopolysaccharide (LPS) activation. MST adsorbed Cd(II), Hg(II), and Au(III) under conditions similar to those in physiological systems. MST exhibited the highest affinity for Cd(II) followed by Hg(II) and Au (III). MST (up to 100 mg/L) exhibited only minor (<25% suppression of succinate dehydrogenase) cytotoxicity and did not trigger TNFalpha secretion nor modulate LPS-induced TNFalpha secretion from monocytes. MST exhibits high affinity for biometals with no significant biological liabilities in these introductory studies. MST deserves further scrutiny as a substance with the capacity to decontaminate biological environments or deliver metals or metal compounds for therapeutic applications.


Asunto(s)
Auranofina/química , Sistemas de Liberación de Medicamentos , Metales Pesados/química , Monocitos , Adsorción , Auranofina/uso terapéutico , Materiales Biocompatibles , Línea Celular , Descontaminación , Humanos , Intercambio Iónico , Lipopolisacáridos/farmacología , Lipopolisacáridos/toxicidad , Ensayo de Materiales , Metales Pesados/uso terapéutico , Monocitos/metabolismo , Monocitos/ultraestructura , Residuos Radiactivos , Succinato Deshidrogenasa/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo
20.
Expert Opin Drug Saf ; 4(4): 769-78, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16011453

RESUMEN

The popularity of traditional remedies has greatly increased in westernised countries over recent years. Although many of these remedies are used safely, there have recently been an increasing number of case reports being published of heavy metal poisoning after the use of traditional remedies, in particular, Indian Ayurvedic remedies. This study reviews the data on published cases, along with the history of Ayurvedic medicine in an attempt to provide an insight into why heavy metals, in particular lead, mercury and arsenic are added in such large concentrations to these remedies.


Asunto(s)
Intoxicación por Metales Pesados , Medicina Ayurvédica , Metales Pesados/uso terapéutico , Preparaciones de Plantas/química , Preparaciones de Plantas/envenenamiento , Historia del Siglo XX , Historia Antigua , Humanos , Medicina Ayurvédica/historia , Metales Pesados/análisis , Metales Pesados/historia , Preparaciones de Plantas/historia , Salud Pública , Factores de Riesgo , Condiciones Sociales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA